← Back
$BIOA All transactions

BioAge Labs, Inc.

M 10b5-1 Plan

$ Value

$22K

Shares

3,383

Price

$7

Filed

Apr 3

Insider

Name

RUBIN PAUL D

Title

Chief Medical Officer

CIK

0001210905

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,820

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024. | This option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024. | The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Filing Info

Accession No.

0001210905-26-000011

Form Type

4

Issuer CIK

0001709941

RUBIN PAUL D's History

Date Ticker Type Value
2026-04-01 BIOA M $22K
2026-04-01 BIOA M $22K
2026-04-01 BIOA $157K
2026-04-01 BIOA M $0
2026-04-01 BIOA M $0
2026-02-17 BIOA A $0
2026-02-02 BIOA M $22K
2026-02-02 BIOA M $13K
2026-02-02 BIOA $139K
2026-02-02 BIOA M $0

Other Insiders at BIOA (90d)

Insider Bought Sold Last
GOLDSTEIN DOV A MD
Chief Financial Officer
2026-02-17
RUBIN PAUL D
Chief Medical Officer
$296K 2026-04-01
Barton Shane
Principal Accounting Officer
2026-02-17
Fortney Kristen
Chief Executive Officer
2026-02-17
Morgen Eric
Chief Operating Officer
2026-02-17